ID   CATF_HUMAN              Reviewed;         484 AA.
AC   Q9UBX1; B2R964; O95240; Q9NSU4; Q9UKQ5;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 157.
DE   RecName: Full=Cathepsin F;
DE            Short=CATSF;
DE            EC=3.4.22.41;
DE   Flags: Precursor;
GN   Name=CTSF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Prostate;
RX   PubMed=10318784; DOI=10.1074/jbc.274.20.13800;
RA   Santamaria I., Velasco G., Pendas A.M., Paz A., Lopez-Otin C.;
RT   "Molecular cloning and structural and functional characterization of
RT   human cathepsin F, a new cysteine proteinase of the papain family with
RT   a long propeptide domain.";
RL   J. Biol. Chem. 274:13800-13809(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Ovary;
RX   PubMed=10198209; DOI=10.1006/bbrc.1999.0461;
RA   Naegler D.K., Sulea T., Menard R.;
RT   "Full-length cDNA of human cathepsin F predicts the presence of a
RT   cystatin domain at the N-terminus of the cysteine protease zymogen.";
RL   Biochem. Biophys. Res. Commun. 257:313-318(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10661872; DOI=10.1515/BC.1999.185;
RA   Wex T., Wex H., Broemme D.;
RT   "The human cathepsin F gene -- a fusion product between an ancestral
RT   cathepsin and cystatin gene.";
RL   Biol. Chem. 380:1439-1442(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10362521; DOI=10.1006/bbrc.1999.0700;
RA   Wex T., Levy B., Wex H., Bromme D.;
RT   "Human cathepsins F and W: a new subgroup of cathepsins.";
RL   Biochem. Biophys. Res. Commun. 259:401-407(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RA   Deussing J., Tisljar K., Papazoglou A., Peters C.;
RT   "Cathepsin F, a novel cysteine protease with an extremely long
RT   propeptide.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 147-484, AND CHARACTERIZATION.
RC   TISSUE=Brain, and Smooth muscle;
RX   PubMed=9822672; DOI=10.1074/jbc.273.48.32000;
RA   Wang B., Shi G.-P., Yao P.M., Li Z., Chapman H.A., Broemme D.;
RT   "Human cathepsin F. Molecular cloning, functional expression, tissue
RT   localization, and enzymatic characterization.";
RL   J. Biol. Chem. 273:32000-32008(1998).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 161-484.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-367; ASN-378 AND ASN-440.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 271-484, ACTIVE SITE, AND
RP   DISULFIDE BONDS.
RX   PubMed=12225749; DOI=10.1016/S0022-2836(02)00780-5;
RA   Somoza J.R., Palmer J.T., Ho J.D.;
RT   "The crystal structure of human cathepsin F and its implications for
RT   the development of novel immunomodulators.";
RL   J. Mol. Biol. 322:559-568(2002).
RN   [12]
RP   VARIANTS CLN13 CYS-231; ARG-321; ALA-458 AND LEU-480.
RX   PubMed=23297359; DOI=10.1093/hmg/dds558;
RA   Smith K.R., Dahl H.H., Canafoglia L., Andermann E., Damiano J.,
RA   Morbin M., Bruni A.C., Giaccone G., Cossette P., Saftig P.,
RA   Groetzinger J., Schwake M., Andermann F., Staropoli J.F., Sims K.B.,
RA   Mole S.E., Franceschetti S., Alexander N.A., Cooper J.D.,
RA   Chapman H.A., Carpenter S., Berkovic S.F., Bahlo M.;
RT   "Cathepsin F mutations cause Type B Kufs disease, an adult-onset
RT   neuronal ceroid lipofuscinosis.";
RL   Hum. Mol. Genet. 22:1417-1423(2013).
CC   -!- FUNCTION: Thiol protease which is believed to participate in
CC       intracellular degradation and turnover of proteins. Has also been
CC       implicated in tumor invasion and metastasis.
CC   -!- CATALYTIC ACTIVITY: The recombinant enzyme cleaves synthetic
CC       substrates with Phe and Leu (better than Val) in P2, with high
CC       specificity constant (k(cat)/K(m)) comparable to that of cathepsin
CC       L.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- TISSUE SPECIFICITY: High expression levels in heart, skeletal
CC       muscle, brain, testis and ovary; moderate levels in prostate,
CC       placenta, liver and colon; and no detectable expression in
CC       peripheral leukocytes and thymus.
CC   -!- DISEASE: Ceroid lipofuscinosis, neuronal, 13 (CLN13) [MIM:615362]:
CC       A form of neuronal ceroid lipofuscinosis characterized by adult
CC       onset of progressive cognitive decline and motor dysfunction
CC       leading to dementia and often early death. Some patients develop
CC       seizures. Neuronal ceroid lipofuscinoses are progressive
CC       neurodegenerative, lysosomal storage diseases characterized by
CC       intracellular accumulation of autofluorescent liposomal material.
CC       {ECO:0000269|PubMed:23297359}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ007331; CAB42883.1; -; mRNA.
DR   EMBL; AF088886; AAD26616.2; -; mRNA.
DR   EMBL; AF132894; AAD41790.1; -; Genomic_DNA.
DR   EMBL; AF136279; AAF13146.1; -; mRNA.
DR   EMBL; AF071748; AAC78838.1; -; mRNA.
DR   EMBL; AF071749; AAC78839.1; -; mRNA.
DR   EMBL; AK313657; BAG36411.1; -; mRNA.
DR   EMBL; BC011682; AAH11682.1; -; mRNA.
DR   EMBL; BC036451; AAH36451.1; -; mRNA.
DR   EMBL; AL137742; CAB70900.1; -; mRNA.
DR   CCDS; CCDS8144.1; -.
DR   RefSeq; NP_003784.2; NM_003793.3.
DR   UniGene; Hs.11590; -.
DR   PDB; 1D5U; Model; -; A=271-484.
DR   PDB; 1M6D; X-ray; 1.70 A; A/B=271-484.
DR   PDBsum; 1D5U; -.
DR   PDBsum; 1M6D; -.
DR   ProteinModelPortal; Q9UBX1; -.
DR   SMR; Q9UBX1; -.
DR   BioGrid; 114261; 10.
DR   STRING; 9606.ENSP00000310832; -.
DR   BindingDB; Q9UBX1; -.
DR   ChEMBL; CHEMBL2517; -.
DR   DrugBank; DB02243; 4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide.
DR   DrugBank; DB01871; [1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester.
DR   DrugBank; DB03536; Benzoyl-Arginine-Alanine-Methyl Ketone.
DR   DrugBank; DB08775; BENZOYL-TYROSINE-ALANINE-METHYL KETONE.
DR   DrugBank; DB07913; HOMOPHENYLALANINYLMETHANE.
DR   DrugBank; DB03691; WRR-112.
DR   DrugBank; DB03573; WRR-99.
DR   GuidetoPHARMACOLOGY; 2347; -.
DR   MEROPS; C01.018; -.
DR   iPTMnet; Q9UBX1; -.
DR   PhosphoSitePlus; Q9UBX1; -.
DR   BioMuta; CTSF; -.
DR   DMDM; 12643325; -.
DR   EPD; Q9UBX1; -.
DR   MaxQB; Q9UBX1; -.
DR   PaxDb; Q9UBX1; -.
DR   PeptideAtlas; Q9UBX1; -.
DR   PRIDE; Q9UBX1; -.
DR   DNASU; 8722; -.
DR   Ensembl; ENST00000310325; ENSP00000310832; ENSG00000174080.
DR   GeneID; 8722; -.
DR   KEGG; hsa:8722; -.
DR   UCSC; uc001oip.4; human.
DR   CTD; 8722; -.
DR   DisGeNET; 8722; -.
DR   GeneCards; CTSF; -.
DR   GeneReviews; CTSF; -.
DR   HGNC; HGNC:2531; CTSF.
DR   HPA; CAB002141; -.
DR   HPA; HPA031431; -.
DR   HPA; HPA055610; -.
DR   MalaCards; CTSF; -.
DR   MIM; 603539; gene.
DR   MIM; 615362; phenotype.
DR   neXtProt; NX_Q9UBX1; -.
DR   OpenTargets; ENSG00000174080; -.
DR   Orphanet; 352709; CLN13 disease.
DR   PharmGKB; PA27031; -.
DR   eggNOG; KOG1542; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   GeneTree; ENSGT00760000118871; -.
DR   HOGENOM; HOG000230774; -.
DR   HOVERGEN; HBG011513; -.
DR   InParanoid; Q9UBX1; -.
DR   KO; K01373; -.
DR   OMA; LAPPEWD; -.
DR   OrthoDB; EOG091G05SD; -.
DR   PhylomeDB; Q9UBX1; -.
DR   TreeFam; TF314550; -.
DR   BRENDA; 3.4.22.41; 2681.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   ChiTaRS; CTSF; human.
DR   EvolutionaryTrace; Q9UBX1; -.
DR   GeneWiki; Cathepsin_F; -.
DR   GenomeRNAi; 8722; -.
DR   PRO; PR:Q9UBX1; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000174080; -.
DR   CleanEx; HS_CTSF; -.
DR   ExpressionAtlas; Q9UBX1; baseline and differential.
DR   Genevisible; Q9UBX1; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:1903561; C:extracellular vesicle; IDA:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; TAS:ProtInc.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IBA:GO_Central.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disease mutation; Disulfide bond;
KW   Glycoprotein; Hydrolase; Lysosome; Neurodegeneration;
KW   Neuronal ceroid lipofuscinosis; Polymorphism; Protease;
KW   Reference proteome; Signal; Thiol protease; Zymogen.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   PROPEP       20    270       Activation peptide.
FT                                /FTId=PRO_0000026202.
FT   CHAIN       271    484       Cathepsin F.
FT                                /FTId=PRO_0000026203.
FT   ACT_SITE    295    295       {ECO:0000269|PubMed:12225749}.
FT   ACT_SITE    431    431       {ECO:0000269|PubMed:12225749}.
FT   ACT_SITE    451    451       {ECO:0000250}.
FT   CARBOHYD    160    160       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    195    195       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    367    367       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    378    378       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    440    440       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID    292    333       {ECO:0000269|PubMed:12225749}.
FT   DISULFID    326    366       {ECO:0000269|PubMed:12225749}.
FT   DISULFID    424    472       {ECO:0000250}.
FT   VARIANT     153    153       Q -> R (in dbSNP:rs11550508).
FT                                /FTId=VAR_051513.
FT   VARIANT     231    231       Y -> C (in CLN13; dbSNP:rs143889283).
FT                                {ECO:0000269|PubMed:23297359}.
FT                                /FTId=VAR_070159.
FT   VARIANT     321    321       Q -> R (in CLN13; dbSNP:rs397514731).
FT                                {ECO:0000269|PubMed:23297359}.
FT                                /FTId=VAR_070160.
FT   VARIANT     458    458       G -> A (in CLN13; dbSNP:rs397514732).
FT                                {ECO:0000269|PubMed:23297359}.
FT                                /FTId=VAR_070161.
FT   VARIANT     480    480       S -> L (in CLN13; dbSNP:rs397514733).
FT                                {ECO:0000269|PubMed:23297359}.
FT                                /FTId=VAR_070162.
FT   CONFLICT    305    305       E -> K (in Ref. 5; AAF13146).
FT                                {ECO:0000305}.
FT   CONFLICT    442    484       SDVPFWAIKNSWGTDWGEKGYYYLHRGSGACGVNTMASSAV
FT                                VD -> EFRCLSCIQPGHRQGWDHSISGPLEGK (in
FT                                Ref. 9). {ECO:0000305}.
FT   HELIX       277    280       {ECO:0000244|PDB:1M6D}.
FT   STRAND      291    293       {ECO:0000244|PDB:1M6D}.
FT   HELIX       295    312       {ECO:0000244|PDB:1M6D}.
FT   HELIX       320    326       {ECO:0000244|PDB:1M6D}.
FT   STRAND      328    330       {ECO:0000244|PDB:1M6D}.
FT   HELIX       338    348       {ECO:0000244|PDB:1M6D}.
FT   TURN        354    356       {ECO:0000244|PDB:1M6D}.
FT   HELIX       370    372       {ECO:0000244|PDB:1M6D}.
FT   STRAND      378    382       {ECO:0000244|PDB:1M6D}.
FT   HELIX       387    397       {ECO:0000244|PDB:1M6D}.
FT   STRAND      400    404       {ECO:0000244|PDB:1M6D}.
FT   HELIX       407    411       {ECO:0000244|PDB:1M6D}.
FT   STRAND      414    417       {ECO:0000244|PDB:1M6D}.
FT   HELIX       421    423       {ECO:0000244|PDB:1M6D}.
FT   STRAND      431    441       {ECO:0000244|PDB:1M6D}.
FT   STRAND      444    450       {ECO:0000244|PDB:1M6D}.
FT   STRAND      462    469       {ECO:0000244|PDB:1M6D}.
FT   HELIX       471    473       {ECO:0000244|PDB:1M6D}.
FT   TURN        474    477       {ECO:0000244|PDB:1M6D}.
FT   STRAND      479    482       {ECO:0000244|PDB:1M6D}.
SQ   SEQUENCE   484 AA;  53366 MW;  1D5D551B489D822B CRC64;
     MAPWLQLLSL LGLLPGAVAA PAQPRAASFQ AWGPPSPELL APTRFALEMF NRGRAAGTRA
     VLGLVRGRVR RAGQGSLYSL EATLEEPPCN DPMVCRLPVS KKTLLCSFQV LDELGRHVLL
     RKDCGPVDTK VPGAGEPKSA FTQGSAMISS LSQNHPDNRN ETFSSVISLL NEDPLSQDLP
     VKMASIFKNF VITYNRTYES KEEARWRLSV FVNNMVRAQK IQALDRGTAQ YGVTKFSDLT
     EEEFRTIYLN TLLRKEPGNK MKQAKSVGDL APPEWDWRSK GAVTKVKDQG MCGSCWAFSV
     TGNVEGQWFL NQGTLLSLSE QELLDCDKMD KACMGGLPSN AYSAIKNLGG LETEDDYSYQ
     GHMQSCNFSA EKAKVYINDS VELSQNEQKL AAWLAKRGPI SVAINAFGMQ FYRHGISRPL
     RPLCSPWLID HAVLLVGYGN RSDVPFWAIK NSWGTDWGEK GYYYLHRGSG ACGVNTMASS
     AVVD
//
